The top 100 stock
market authors
selected for publication in the last week
market authors
selected for publication in the last week
You are currently following TheOpioidTruth
Stop FollowingYou are no longer following TheOpioidTruth
-
0
)
Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone [View article]
Aside from a pro-drug approach like NRP's which cannot be used for analgesics.
Acura' Acurox: A Revenue-Deterrent Formulation of Oxycodone [View article]